Restless legs syndrome severity in the National RLS Opioid Registry during the COVID-19 pandemic

Restless legs syndrome severity in the National RLS Opioid Registry during the COVID-19 pandemic

Objective/background: No research has yet assessed the impact of the coronavirus disease 2019 (COVID-19) pandemic on restless legs syndrome (RLS). We hypothesized that RLS symptom severity would be increased during the COVID-19 pandemic in a sample of patients with diagnosed RLS. Patients/methods: T...

Full description

Bibliographic Details
Main Authors: Romero-Gutierrez, C. (Author), Winkelman, J.W (Author), Wipper, B. (Author)
Format: Article
Language:English
Published: Elsevier B.V. 2022
Subjects:
Analgesics, Opioid
Anxiety
anxiety disorder
Article
coronavirus disease 2019
COVID-19
demography
depression
Depression
disease registry
disease severity
disease severity assessment
Generalized Anxiety Disorder-7
health care survey
human
Humans
Insomnia
Insomnia Severity Index
International Restless Legs Syndrome Study Group Severity Scale
longitudinal study
major clinical study
narcotic analgesic agent
observational study
opiate
pandemic
Pandemics
Patient Health Questionnaire 9
population research
questionnaire
register
Registries
restless legs syndrome
Restless legs syndrome
Restless Legs Syndrome
severity of illness index
Severity of Illness Index
sleep disorder
social status
Surveys and Questionnaires
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items